How Your Thyroid Controls Your Testosterone (Check This Before TRT)

Your thyroid is upstream of your testosterone, and most clinics never check it.

That sentence sounds simple, but the mechanism behind it explains why thousands of men go on testosterone replacement therapy, feel better for a while, and then plateau or never quite feel right. It explains why some men using growth hormone peptides get no response. And it explains why fixing one hormone without looking at the whole system is like replacing a light bulb in a house with no electrical current running to it.

To understand why, you need the map first.

Your hypothalamus and pituitary gland act as a shared command center for your entire hormonal system, and through that command center runs three separate axes: the thyroid axis, the testosterone axis, and the growth hormone axis. Each one follows the same relay pattern. Your hypothalamus sends a releasing hormone down to your pituitary, your pituitary sends a stimulating hormone to a target gland, that gland produces its hormone, and the hormone feeds back up to the brain to regulate the signal. Three systems, same infrastructure, same relay stations.

That shared infrastructure is exactly why they influence each other.

The thyroid axis works like this. Your hypothalamus produces something called TRH, or thyrotropin releasing hormone, which signals the pituitary to release TSH, or thyroid stimulating hormone. TSH tells your thyroid gland to produce T4 and T3. T4 makes up about 80 percent of what your thyroid puts out, and T3 makes up the remaining 20 percent. But here is what those numbers actually mean functionally: T4 is a storage form that your body cannot directly use, and T3 is the biologically active form that actually does the work. T4 has to be converted into T3 by enzymes called deiodinases before your cells can respond to it.

Think of T4 as raw material sitting in a warehouse, and the deiodinase enzymes as the workers who process that raw material into finished product. If you do not have enough workers, raw material accumulates and finished product runs short. Those enzymes require selenium to function, which is why selenium deficiency directly raises the ratio of T4 to T3, meaning the raw material is there but the processing is impaired.

There is also a third pathway that matters here. T4 can be converted not into active T3 but into something called reverse T3, which is an inactive form that actually competes with T3 for receptor binding. Chronic cortisol elevation pushes T4 down this inactivation pathway within hours, which means a person under sustained stress can have normal TSH, normal T4, and still be functionally hypothyroid because their active T3 is being diverted away. Standard testing never catches this.

Now, the testosterone axis follows the exact same relay pattern. Your hypothalamus produces GnRH, your pituitary responds with LH and FSH, and LH travels to the Leydig cells in your testes to trigger testosterone production. Two systems, same relay stations, and this is not a coincidence in terms of how they interact.

Thyroid hormone directly controls testosterone production through three distinct mechanisms.

The first is at the pituitary level, where T3 modulates how strongly your pituitary responds to the GnRH signal coming from your hypothalamus. In hypothyroidism, the pituitary receives that GnRH signal but produces an inadequate LH response, so the signal gets sent but the relay station does not pass it forward with enough force. The result is a pattern called hypogonadotropic hypogonadism, which means low testosterone paired with low or inappropriately normal LH. The testes are fine and capable of producing testosterone, but they are not receiving an adequate signal to do so. A 2000 study by Donnelly and White measured this directly: free testosterone in men with primary hypothyroidism was 161 pmol/L on average, and after thyroxine replacement it nearly doubled to 315 pmol/L, with the pattern confirming the problem was coming from the brain relay, not from the testes.

The second mechanism is at the Leydig cell itself. Your Leydig cells have thyroid hormone receptors, and T3 directly increases the number of LH receptors on those cells, making them more sensitive to whatever LH signal they do receive. T3 also upregulates something called StAR protein, which stands for steroidogenic acute regulatory protein and which controls the rate limiting step in testosterone synthesis by transporting cholesterol into the mitochondria where production begins. Maran and colleagues found that T3 induced a 260 percent increase in StAR protein expression in Leydig cells. Your thyroid hormone is controlling how much raw material gets into the factory where testosterone is made.

The third mechanism involves SHBG, or sex hormone binding globulin, which is a protein your liver produces that binds to testosterone and makes it biologically unavailable. Thyroid status directly influences how much SHBG your liver produces, so a thyroid problem changes the interpretation of your testosterone numbers even before you account for the production effects.

A conference abstract from Shrivastav and Saboo looked at 51 men with overt hypothyroidism and found that 50 percent had low testosterone at baseline. After levothyroxine normalized their thyroid function, 70 percent of those men had their testosterone return to normal without any testosterone treatment at all. This was a conference abstract and not a peer reviewed study, so the data carries less weight than a full publication, but it is directionally consistent with the Donnelly findings and with every mechanism described above.

The same upstream dependency applies to growth hormone. Your pituitary contains cells called somatotrophs that produce growth hormone, and these cells need adequate T3 to properly express the receptors that receive the growth hormone releasing signal from your hypothalamus. Miki and colleagues showed that hypothyroidism depressed the growth hormone response to GHRH and that T3 treatment restored it. But the connection extends further than natural GH release. Your pituitary also contains something called the growth hormone secretagogue receptor, which is the receptor that peptides like ipamorelin and MK-677 are targeting when you use them. Kamegai and colleagues found in 2001 that T3 increases expression of this receptor by extending its mRNA half life from 8 hours to 15 hours in rat pituitary cells. This was an in vitro animal study, so direct human confirmation is lacking, but the mechanism suggests that if your thyroid is suboptimal, you have fewer of the exact receptors your peptides depend on.

The order of operations is now clear. Thyroid sits upstream of testosterone production at both the pituitary relay and the production site, and thyroid sits upstream of growth hormone response by controlling the receptor density that peptides are trying to activate.

So what does a complete evaluation actually look like before making any decisions about treatment.

TSH alone is not sufficient, because TSH can be entirely normal while active T3 is low and reverse T3 is elevated. That constellation is called functional hypothyroidism and standard panels miss it entirely. A complete thyroid panel means TSH, free T3, free T4, and reverse T3. Alongside that, you want total testosterone, free testosterone, LH to establish whether you are dealing with a testicular problem or a signaling problem, and SHBG to properly contextualize the testosterone numbers.

If the thyroid picture is suboptimal but not yet a medical diagnosis, there are nutritional foundations worth addressing first. Selenium at 200 micrograms per day is the studied dose for supporting T4 to T3 conversion, and you should not exceed 400. Zinc at 30 milligrams daily supports both TRH synthesis and thyroid hormone receptor function. Iron deficiency reduces the activity of thyroid peroxidase, the enzyme your thyroid needs to produce T4 and T3 in the first place, with research in rats showing TPO activity drops 33 to 56 percent under iron deficiency, so ferritin is worth checking. Iodine is the structural building block of both T4 and T3, but supplementing without confirmed deficiency can worsen autoimmune thyroid conditions like Hashimoto's. And chronic stress management is not a soft recommendation here because cortisol actively shifts T4 conversion toward reverse T3 and away from active T3, meaning the psychological and the physiological are directly linked in the thyroid system.

When natural optimization is not enough, it is not enough. Hashimoto's thyroiditis is an autoimmune condition and does not respond to selenium and zinc. True hypothyroidism with elevated TSH and low thyroid hormones requires levothyroxine under medical supervision, and over replacement carries real risks including bone loss, cardiac arrhythmia, and anxiety. The goal is a calibrated panel and a calibrated response.

Most people think of their hormones as separate dials. Testosterone is one dial, thyroid is another, growth hormone is a third. But they are not separate dials. They are the same system running through the same control center, and thyroid sits first in the sequence. When you treat testosterone without looking at thyroid, you are adjusting a downstream output without asking why the output was low in the first place.

That is not optimization. That is substitution.

---

References

1. Donnelly P, White C. 2000. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clinical Endocrinology, 522:197-201. Free testosterone nearly doubled 161 to 315 pmol/L after thyroxine replacement in hypothyroid men. Source
2. Shrivastav A, Saboo B. 2022. Effect of levothyroxine replacement therapy on testosterone, LH, FSH levels in men with overt hypothyroidism. ECE2022 Conference Abstract, Endocrine Abstracts, 81, P730. 70% of hypogonadal hypothyroid patients had testosterone normalize after levothyroxine. Conference abstract, N=51. Source
3. Maran RR, et al. 2000. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells. Endocrinology, 14112:4468-4477. T3 increases LH receptor numbers, StAR protein 260% increase, and steroidogenic enzyme expression in Leydig cells. Source
4. Kamegai J, et al. 2001. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. Journal of Neuroendocrinology, 133:275-278. T3 increased GHS-R mRNA by extending half-life from 8h to 15h in rat pituitary cells. Source
5. Miki N, et al. 1989. Effects of hypothyroidism, T3 and glucocorticoids on GH responses to GHRH. Journal of Endocrinology, 122:585-591. Hypothyroidism depressed growth hormone response to GHRH; T3 treatment restored it. Source
6. Winther KH, et al. 2020. Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio. BMC Endocrine Disorders. Selenium deficiency directly associated with impaired T4 to T3 conversion. Source
7. Hess SY, et al. 2002. Iron deficiency anemia reduces thyroid peroxidase activity in rats. Journal of Nutrition, 1327:1951-1955. Iron deficiency reduced TPO activity by 33-56%. Source
8. Chopra IJ, et al. 1975. Opposite effects of dexamethasone on serum concentrations of reverse T3 and T3. Journal of Clinical Endocrinology and Metabolism. Cortisol shifts T4 metabolism toward reverse T3 within hours. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness